AFC-HD AMS Life Science Co., Ltd. (TYO:2927)

Market Cap	12.01B
Revenue (ttm)	32.26B
Net Income (ttm)	1.49B
Shares Out	14.06M
EPS (ttm)	106.01
PE Ratio	8.06
Forward PE	n/a
Dividend	32.00 (3.73%)
Ex-Dividend Date	Aug 28, 2025

Volume	4,600
Average Volume	7,650
Open	860.00
Previous Close	854.00
Day's Range	856.00 - 860.00
52-Week Range	735.00 - 953.00
Beta	0.36
RSI	52.80
Earnings Date	Jul 15, 2025

About AFC-HD AMS Life Science

AFC-HD AMS Life Science Co., Ltd. operates as an original equipment manufacturer of health foods and cosmetics. The company operates through five segments: Healthcare, Pharmaceutical, Department Store, Food and Beverage, and Other Business. The Healthcare segment manufactures, sells, and supplies OEM health foods, such as tablets, capsules, granules, soft drinks, and jelly; and cosmetics, including skin care and hair care products. This segment also operates as an advertising agency focused on planning and producing health information programs,...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1969
• Employees: 994
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2927

Financial Performance

In 2024, AFC-HD AMS Life Science's revenue was 30.19 billion, an increase of 18.01% compared to the previous year's 25.58 billion. Earnings were 1.25 billion, an increase of 13.61%.